Uniting oncologists for borderless exchange
Uniting healthcare professionals for
borderless exchange in oncology
All roundtable sessions accredited
Join us forour roundtable about||latest advances for||your questions about||new therapies with||practice changes with||your patient cases around
|Welcome & introduction by host||Solange Peters|
|Druggable since 2023: an overview of newly approved therapies
for lung cancer in Switzerland
|Highlights of the year in targeted therapies||Pasi Jänne|
|Highlights of the year in immunotherapies||Hossein Borghaei|
Join us for a comprehensive review of the latest advances in metastatic lung cancer in 2023. Our host, Solange Peters, cordially invites you to this year's update, featuring a distinguished panel of experts specializing in targeted therapies and immuno-oncology. Together, we will delve into practice-changing research and the most recent treatment approvals in the field. Don't miss this valuable opportunity to enhance your understanding of optimizing lung cancer treatment, based on the latest evidence. Engage in the conversation, submit your questions, and uncover the significant discoveries that are shaping today's approach to lung cancer treatment.
Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.
First Time On OncoViews?
2 CME Points
SGMO • SSOM • SSMO
This session is kindly supported by our partners with no influence on the content